- Usefulness of Lactulose Breath Test for the Prediction of Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome
-
Park JS, Yu JH, Lim HC, Kim JH, Yoon YH, Park HJ, Lee SI
- KMID: 1718360
- Korean J Gastroenterol.
- 2010 Oct;56(4):242-248.
- doi: 10.4166/kjg.2010.56.4.242
BACKGROUND/AIMS: Lactulose breath test (LBT) has been used as a presumptive surrogate marker for small intestinal bacterial overgrowth (SIBO). However, recent reports suggest that abnormal LBT cannot discriminate patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
-
Bae S, Lee KJ, Kim YS, Kim KN
- KMID: 2160605
- J Korean Med Sci.
- 2015 Jun;30(6):757-762.
- doi: 10.3346/jkms.2015.30.6.757
Small intestinal bacterial overgrowth (SIBO) can partly explain irritable bowel syndrome (IBS), and rifaximin has been observed to improve abdominal symptoms in nonconstipated IBS patients. However, there are few reports... -
- CITED
-
- Close
- SHARE
-
- Close
